Advertisement
YOU ARE HERE: LAT HomeCollectionsDiabetes
IN THE NEWS

Diabetes

FEATURED ARTICLES
HEALTH
May 2, 2005 | Elena Conis
Banaba is the Tagalog name for the tree dubbed "pride of India" (more scientifically known as Lagerstroemia speciosa). The purple-flowered tree grows in tropical parts of the Americas, India and the Philippines, where it's used in traditional medicine to treat diabetes. The tree's glossy leaves contain high levels of colosolic acid, a plant chemical that reputedly lowers blood sugar levels.
ARTICLES BY DATE
SCIENCE
April 24, 2014 | By Deborah Netburn
Drinking more coffee may decrease your risk of developing Type 2 diabetes, a new study shows. Researchers from Harvard University found that people who increased their coffee consumption by at least one cup per day over a period of years were 11% less likely to get Type 2 diabetes compared with people whose coffee-drinking habits didn't change. On the flip side, people who dialed back their coffee habit by at least one cup a day were 17% more likely to develop Type 2 diabetes.
Advertisement
NEWS
April 18, 2011 | By Thomas H. Maugh II, Los Angeles Times
Type 2 diabetes, like Type 1, may be an autoimmune disease, but the immune system's target cells are different, Stanford researchers said Sunday. The discovery sheds new light on how obesity contributes to the onset of Type 2 diabetes and could lead to new types of treatment for the disorder, the researchers reported in the journal Nature Medicine. Diabetes is a growing problem in the United States, triggered in large part by the obesity epidemic. An estimated 27 million Americans are now thought to have diabetes, with the vast majority of them -- all but about a million -- afflicted with Type 2 diabetes.
BUSINESS
April 2, 2014 | By Stuart Pfeifer
MannKind Corp. shares were up nearly 80% Wednesday after the Valencia company said an FDA advisory panel had backed its inhaled diabetes drug that could replace most insulin injections. The panel voted 13-1 to recommend that the FDA approve the drug, Afrezza, for the treatment of Type 1 diabetes and 14-0 to approve it for the more common Type 2 diabetes. The FDA doesn't have to follow the panel's recommendation, but the panel's nod was considered a key hurdle for the company.
NEWS
August 12, 2010
A surgical procedure that reduces pressure on the blood vessels of a brain region that regulates the body's vital functions appears, in some cases, to improve glucose control in patients with type-2 diabetes, a group of Pittsburgh physicians report . Writing in the journal Surgical Neurology International> , a team of physicians report that by lifting and repositioning an artery that lay across the vagus nerve, they effected improvements in...
NEWS
September 22, 2010
The basics In the simplest terms, diabetes means having too much glucose in your blood. Glucose is a type of sugar and a source of energy for the body. But if insulin, glucose’s “traffic cop,” isn’t doing its job, glucose accumulates in the bloodstream and all sorts of health problems can occur. Normally, most of the food a person eats gets converted into glucose, the body’s energy of choice. The circulatory system shuttles the glucose around so that hungry cells in the muscles, liver and elsewhere can snatch it out of the blood as it passes by. The liver cells are the hungriest for that glucose, because the liver is the body’s between-meal glucose storage facility.
BUSINESS
February 17, 2011 | David Lazarus
David Martin was in the mood for raw fish, and he liked the deal offered by a Studio City sushi restaurant: all you can eat for $28. He took a seat at the counter and started ordering. But it turned out that Martin didn't really want sushi, which includes rice; he wanted all-you-can-eat sashimi, which is just fish. He began picking the seafood off the top and leaving the rice. Restaurant owner Jay Oh told Martin that if he wanted the all-you-can-eat price, he'd have to eat the rice too and not just fill up on fish.
NEWS
May 20, 2011 | By Shari Roan, Los Angeles Times / For the Booster Shots blog
Latinos have higher rates of diabetes than other ethnic groups. They also appear to have higher rates of having both diabetes and a mood disorder, such as anxiety or depression, according to a new study presented this week at the American Psychiatric Assn.'s annual meeting. Researchers examined the medical records 129 adults diagnosed with diabetes at a rural health clinic in Imperial County, in California, to assess the rates of mood disorders in diabetic Latinos and to determine which illness appeared first.
NEWS
November 8, 2011 | By Amina Khan, Los Angeles Times / For the Booster Shots blog
Former undisputed heavyweight boxing champion Joe Frazier, who died Monday at the age of 67 after a brief bout with liver cancer, also had diabetes -- a major risk factor associated with the disease. Diabetes has been associated with the highest percentage (34%) of cases of the most common type of liver cancer, according to research by the National Cancer Institute. (The next highest was alcohol-related disorders, with 24%). Men and older adults are at higher risk of the cancer as well.
NEWS
June 20, 2012 | By Rosie Mestel, Los Angeles Times / For the Booster Shots blog
After gastric bypass surgery, people with  Type 2 diabetes often see their disease completely  disappear  - within weeks, before they've lost much or any weight. It doesn't work for everyone, though.  What are the factors that matter? A study by a team of scientists from the University of Massachussetts looked into that. Here are their findings, which were presented at the annual meeting of the American Society for Metabolic and Bariatric Surgery. The scientists looked at remission of diabetes in 139 patients, ages 48 to 57, who'd had gastric bypass surgery.
SCIENCE
March 31, 2014 | By Melissa Healy
Bariatric surgery did more to improve symptoms of diabetes, high blood pressure and high cholesterol after three years than intensive treatment with drugs alone, according to new results from a closely watched clinical trial involving patients who were overweight or obese. Study participants who had gastric bypass surgery or sleeve gastrectomy also lost more weight, had better kidney function and saw greater improvements in their quality of life than their counterparts who did not go under the knife, researchers reported Monday.
BUSINESS
January 16, 2014 | By Jessica Guynn
SAN FRANCISCO -- Google is searching for a better way for millions of diabetics to manage their disease by developing a contact lens that monitors glucose levels in tears. The contact lenses are the latest project from Google's secretive X lab that also came up with the driverless car, the Internet-connected eyewear Glass, and Project Loon, which is using balloons to bring the Internet to far-flung places. The "smart" contact lens uses a tiny wireless chip and miniature glucose sensor that is folded into two layers of soft contact lens material.
SCIENCE
January 15, 2014 | By Karen Kaplan
For people with Type 2 diabetes who had hoped that their love handles might serve some purpose by reducing their risk of premature death, Harvard researchers have some bad news: The “obesity paradox” does not exist. “We found no evidence of lower mortality among patients with diabetes who were overweight or obese at diagnosis, as compared with their normal-weight counterparts, or of an obesity paradox,” the research team reported in a study that appears in Thursday's edition of the New England Journal of Medicine.
SCIENCE
January 8, 2014 | By Melissa Healy
The Food and Drug Administration on Wednesday approved U.S. marketing of the drug dapagliflozin, the second of a new class of medications that aim to improve glycemic control in patients with Type 2 diabetes. The drug will be marketed under the name Farxiga. Dapagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor, a drug that blocks the reabsorption of glucose by the kidney, increases the excretion of glucose in urine and lowers glucose levels in the blood. It will join -- and is likely to be prescribed in conjunction with -- a wide range of diabetes medications, including metformin, pioglitazone, glimepiride, sitagliptin and insulin.
SCIENCE
January 6, 2014 | By Melissa Healy
Even without weight loss, adhering to a diet rich in fresh produce, chicken, fish and olive oil is 40% more effective in heading off the development of Type 2 diabetes than following a low-fat diet, a new study has found. The research suggests that for the nation's 78 million obese adults, a diet that minimizes red meat and sweets but incorporates plant-based fats may be a sustainable way to improve health - even if permanent weight reduction proves elusive. The findings add to mounting research that suggests a traditional Mediterranean diet may be easier to adhere to and more likely to improve health than more restrictive regimens.
CALIFORNIA | LOCAL
December 24, 2013 | By Eryn Brown
Guillermina Villa is famous for the seafood she prepares at El Pescadito Tacos y Mariscos, a lunch truck that has been serving customers for more than 25 years near the intersection of Compton Avenue and 62nd Street in South L.A.'s Florence-Firestone neighborhood. Customers who grew up in the largely industrial area travel great distances - from as far as North Hollywood, Rancho Cucamonga and Oxnard - to treat themselves to favorites like shrimp tacos and empanadas. But these days a new sign on Villa's truck advertises a smattering of new menu items such as quesadillas made with whole wheat tortillas and ceviche served with a side of plain yogurt and fruit.
NEWS
November 23, 2010 | By Mary Forgione, For the Los Angeles Times
Type 2 diabetes is rising -- markedly -- in the United States, and it's fueling more than just costs associated with treating the disease. It's also fueling a backlash among some Type 1 diabetics. They bristle at being lumped in with the "lifestyle" crowd. Type 2 diabetics, whose bodies don't produce insulin efficiently, can often control their disease by changing their diet and exercise habits. Not so Type 1 diabetics, whose bodies are unable to produce insulin.   In terms of a price tag, an analysis released Tuesday by healthcare insurer UnitedHealth Group says costs associated with this disease could hit $3.35 trillion by 2020 if current trends continue and half of Americans are diagnosed with diabetes or pre-diabetes.
NEWS
January 9, 2012 | By Jeannine Stein, Los Angeles Times / For the Booster Shots blog
The health consequences of diabetes are well known for young people, but there may be more outcomes of the disease: a worse job outlook and lower wages. The findings come from a study published in the January issue of the journal Health Affairs . Researchers, focusing on the nonmedical effects diabetes has on teens and young adults, found that overall, people with diabetes have a high school dropout rate 6% higher than those who don't have the disease. Data on about 15,000 people were examined from four waves of the National Longitudinal Study of Adolescent Health.
BUSINESS
December 8, 2013 | By Ronald D. White
MannKind Corp. in Valencia is attempting to revolutionize the treatment of Type 1 and Type 2 diabetes with its first product: an inhaled form of insulin powder called Afrezza that would eliminate the need for most injections. The company hopes to get federal approval for the Afrezza inhaler system by spring. The company's future and that of its 246 employees are riding on that goal. The dream of an inhaled form of insulin treatment dates from the 1920s, when doctors and researchers worried that diabetes patients wouldn't want to subject themselves to regular injections.
SCIENCE
December 5, 2013 | By Melissa Healy
A class of oral diabetes medications that has drawn controversy in recent years reduces the risk of cancer in women taking it by almost a third, says a large new study conducted by researchers at the Cleveland Clinic . In preventing cancer, the researchers found that insulin sensitizers, including the drugs metformin, rosiglitazone and pioglitazone (the latter two marketed as Avandia and Actos) were more powerful than insulin secretagogues such as glyburide, glipizide and glimepiride.
Los Angeles Times Articles
|